The American journal of managed care
-
Observational Study
Association of physician specialty with psoriatic arthritis treatment and costs.
To describe current psoriatic arthritis treatment and costs by provider specialty using real-world claims data. ⋯ In patients with newly diagnosed psoriatic arthritis, physician specialty was associated with different medication choices but not costs.
-
To examine whether enrollment in Medicare Advantage (MA) and fee-for-service traditional Medicare (TM) is differential by food insecurity and then examine differences in health care utilization, financial burden, care satisfaction, and health status between food-insecure enrollees in MA and TM and between food-secure enrollees in MA and TM. ⋯ MA may deliver care more efficiently to food-insecure beneficiaries than TM, but it is not better at reducing food insecurity.
-
To measure variation in spending and inpatient prices associated with the primary care physician (PCP) practice to which patients are attributed. ⋯ There are meaningful opportunities to reduce spending by changing patient PCP selection, encouraging patients to use lower-priced specialists and hospitals, and eliminating wasteful care. Attention must be paid to the best ways to reap these savings.
-
As the number of inpatients with advanced age and chronic conditions rises, so too does the need for inpatient palliative care (PC). Despite the strong evidence base for PC, less than 50% of all inpatient PC needs are met by inpatient consults. ⋯ In this article, we explore how PC innovations during COVID-19 could transform the PC consult to address workforce shortages and expand access to PC services during and beyond the pandemic. We propose a 3-pronged strategy of bolstering inpatient telepalliative care services, expanding electronic consults, and increasing training and educational tools for providers to help meet the increased need for PC services in the future.
-
Inflammatory bowel disease (IBD) is associated with extraintestinal manifestations in more than one-quarter of patients. Anemia is one of the most common concerns. Patients with IBD and comorbid iron deficiency anemia (IDA) are at risk for hospitalization and surgery, and IDA impacts health-related quality of life. ⋯ Although the treatment goals for IDA in IBD are well-defined, selecting a treatment is not as straightforward. Traditional oral iron replacement therapies are generally only recommended in patients with mild anemia who do not have active inflammatory disease. Novel oral iron formulations may circumvent some of the limitations associated with traditional oral products.